(1S)-(+)-(10-Camphorsulfonyl)oxaziridine CAS 104322-63-6 Ubunyulu ≥98.5% (HPLC) Ucoceko oluPhezulu
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
(1S)-(+)-(10-Camphorsulfonyl)oxaziridine CAS 104322-63-6
(1R)-(-)-(10-Camphorsulfonyl)oxaziridine CAS 104372-31-8
IiCompounds zeChiral, uMgangatho oPhezulu, iMveliso yoRhwebo
Igama leMchiza | (1S)-(+)-(10-Camphorsulfonyl)oxaziridine |
Izithethantonye | (1S)-(+)-(Camphorylsulfonyl)oxaziridine;(2R,8aS)-(+)-(Camphorylsulfonyl)oxaziridine |
Inombolo yeCAS | 104322-63-6 |
Inombolo yeCAT | RF-CC267 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C10H15NO3S |
Ubunzima beMolekyuli | 229.3 |
Imeko yokuthumela ngenqanawa | Ithunyelwe Ngaphantsi Kweqondo Lobushushu Le-Ambient |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe oMhlophe oMthubi oMthubi |
Ubunyulu | ≥98.5% (HPLC) |
Indawo yokunyibilika | 168.0 ~ 172.0℃ |
Ukujikeleziswa okuthe ngqo [a]D20 | +43.0 ° ~ +47.0 ° (C=2.3, Kwi-CHCl3) |
Ilahleko ekomisweni | ≤1.0% |
Intsalela kwi-Ignition | ≤0.30% |
Iintsimbi ezinzima (Pb) | ≤20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | IiCompounds zeChiral;AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, Igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi (1S)-(+)-(10-Camphorsulfonyl)oxaziridine (CAS: 104322-63-6) kunye nomgangatho ophezulu.
(1S)-(+)-(10-Camphorsulfonyl)oxaziridine (CAS: 104322-63-6) i-Camphor derivative eluncedo, i-synthetic intermediate esebenzayo.Isetyenziselwa i-asymmetric hydroxylation.
(1S)-(+)-(10-Camphorsulfonyl)oxaziridine (CAS: 104322-63-6) ingasetyenziswa:
Ukuguqula i-prochiral ketone enolates ibe yi-optically active α-hydroxy ketones nge-enantioselective asymmetric oxidation.
Kwi-synthesis ye-thymidine oligonucleotides exhunywe nge-pyrophosphates.
Kwi-asymmetric synthesis yeproton pump inhibitors njenge (R) -Rabeprazole sodium kunye (R) -Lansoprazole sodium evela kwi-DBU ehambelana netyuwa yeprochiral sulfide.
Ekulungiseleleni i-phosphonoacetate kunye ne-thiophosphonoacetate oligodeoxynucleotides nge-oxidizing i-phosphinoacetate ehambelanayo.